Back to ProShare Advisors LLC ProShare Advisors LLC

OCDXOCDX
6 quarters

Position history for ProShare Advisors LLCProShare Advisors LLC's holdings in ORTHO CLINICAL DIAGNOSTICS H

As of its Q1 2022 13F, ProShare Advisors held 22,586 shares of OCDX (Ortho Clinical Diagnostics), worth $422,000. ProShare Advisors' 13F filings listed OCDX from Q1 2021 to Q1 2022, 5 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$455,000

Total Shares Change

-23,580

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2022-Q2
Latest
Exited
0
-100.0%
$00.0%—
0
2022-Q1
Decreased
22,586
-14.2%
$422,0000.0%—
0
2021-Q4
Increased
26,310
+85.5%
$563,0000.0%—
38
2021-Q3
Decreased
14,187
-38.2%
$262,0000.0%—
0
2021-Q2
Decreased
22,958
-2.6%
$492,0000.0%—
0
2021-Q1
New
23,580
-
$455,0000.0%—
33

Other major holders of OCDX: Carlyle Group Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used